New Perspectives on the Biogenesis of Viral Inclusion Bodies in Negative-Sense RNA Virus Infections.

Olga Dolnik, Gesche K Gerresheim, Nadine Biedenkopf
Author Information
  1. Olga Dolnik: Institute for Virology, Philipps-University Marburg, 35043 Marburg, Germany. ORCID
  2. Gesche K Gerresheim: Institute for Virology, Philipps-University Marburg, 35043 Marburg, Germany.
  3. Nadine Biedenkopf: Institute for Virology, Philipps-University Marburg, 35043 Marburg, Germany. ORCID

Abstract

Infections by negative strand RNA viruses (NSVs) induce the formation of viral inclusion bodies (IBs) in the host cell that segregate viral as well as cellular proteins to enable efficient viral replication. The induction of those membrane-less viral compartments leads inevitably to structural remodeling of the cellular architecture. Recent studies suggested that viral IBs have properties of biomolecular condensates (or liquid organelles), as have previously been shown for other membrane-less cellular compartments like stress granules or P-bodies. Biomolecular condensates are highly dynamic structures formed by liquid-liquid phase separation (LLPS). Key drivers for LLPS in cells are multivalent protein:protein and protein:RNA interactions leading to specialized areas in the cell that recruit molecules with similar properties, while other non-similar molecules are excluded. These typical features of cellular biomolecular condensates are also a common characteristic in the biogenesis of viral inclusion bodies. Viral IBs are predominantly induced by the expression of the viral nucleoprotein (N, NP) and phosphoprotein (P); both are characterized by a special protein architecture containing multiple disordered regions and RNA-binding domains that contribute to different protein functions. P keeps N soluble after expression to allow a concerted binding of N to the viral RNA. This results in the encapsidation of the viral genome by N, while P acts additionally as a cofactor for the viral polymerase, enabling viral transcription and replication. Here, we will review the formation and function of those viral inclusion bodies upon infection with NSVs with respect to their nature as biomolecular condensates.

Keywords

References

  1. J Mol Biol. 2016 Aug 28;428(17):3467-82 [PMID: 27487481]
  2. J Virol. 2000 Apr;74(8):3899-904 [PMID: 10729166]
  3. J Virol. 2002 Feb;76(4):1825-38 [PMID: 11799178]
  4. FASEB J. 2014 Jun;28(6):2504-16 [PMID: 24599967]
  5. Virology. 2017 Feb;502:73-83 [PMID: 28013103]
  6. Dev Cell. 2020 Oct 12;55(1):30-44 [PMID: 32726575]
  7. J Gen Virol. 2002 Apr;83(Pt 4):753-757 [PMID: 11907323]
  8. J Infect Dis. 2015 Oct 1;212 Suppl 2:S322-8 [PMID: 26092855]
  9. Arch Virol. 2007;152(12):2259-63 [PMID: 17703289]
  10. J Virol. 2005 Nov;79(21):13421-33 [PMID: 16227263]
  11. J Virol. 2015 Jan 15;89(2):917-30 [PMID: 25355874]
  12. mBio. 2014 Nov 04;5(6):e02011 [PMID: 25370495]
  13. Cells. 2020 Jan 11;9(1): [PMID: 31940815]
  14. Mol Cell Proteomics. 2015 Mar;14(3):532-43 [PMID: 25556234]
  15. Front Microbiol. 2019 Feb 01;10:95 [PMID: 30792702]
  16. Mol Genet Genomics. 2020 Nov;295(6):1501-1516 [PMID: 32767127]
  17. J Virol. 2006 Jun;80(11):5168-78 [PMID: 16698997]
  18. Biol Cell. 2005 Feb;97(2):147-72 [PMID: 15656780]
  19. mBio. 2020 Sep 22;11(5): [PMID: 32963000]
  20. J Gen Virol. 2010 Jun;91(Pt 6):1478-83 [PMID: 20164259]
  21. PLoS One. 2018 Aug 2;13(8):e0201827 [PMID: 30071116]
  22. Virology. 2017 Dec;512:39-47 [PMID: 28915404]
  23. Front Cell Dev Biol. 2021 Mar 18;9:640456 [PMID: 33816489]
  24. Nat Commun. 2017 Sep 15;8(1):563 [PMID: 28916773]
  25. J Gen Virol. 2009 Sep;90(Pt 9):2147-56 [PMID: 19458173]
  26. J Virol. 2020 Oct 27;94(22): [PMID: 32878896]
  27. J Interferon Cytokine Res. 2006 May;26(5):271-80 [PMID: 16689655]
  28. J Virol. 2009 Sep;83(17):8993-7 [PMID: 19515768]
  29. Viruses. 2019 Jun 01;11(6): [PMID: 31159413]
  30. Curr Opin Microbiol. 2011 Aug;14(4):504-10 [PMID: 21824806]
  31. Curr Opin Virol. 2017 Jun;24:105-114 [PMID: 28601688]
  32. Cell Microbiol. 2013 Feb;15(2):200-12 [PMID: 23046288]
  33. Nat Commun. 2020 Nov 18;11(1):5885 [PMID: 33208793]
  34. Virus Res. 2009 Mar;140(1-2):8-14 [PMID: 19041915]
  35. J Infect Dis. 2011 Nov;204 Suppl 3:S934-40 [PMID: 21987772]
  36. Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):5952-7 [PMID: 15069200]
  37. Nat Commun. 2019 Apr 9;10(1):1629 [PMID: 30967547]
  38. PLoS Pathog. 2014 Oct 16;10(10):e1004463 [PMID: 25330247]
  39. J Interferon Cytokine Res. 2009 Sep;29(9):511-20 [PMID: 19694547]
  40. Angew Chem Int Ed Engl. 2017 Sep 11;56(38):11354-11359 [PMID: 28556382]
  41. Nucleic Acids Res. 2007;35(11):3602-11 [PMID: 17485480]
  42. Science. 2018 May 25;360(6391):918-921 [PMID: 29650702]
  43. Cell Rep. 2018 Feb 6;22(6):1401-1412 [PMID: 29425497]
  44. Virology. 1993 Jul;195(1):243-7 [PMID: 8317099]
  45. Science. 2017 May 19;356(6339):753-756 [PMID: 28522535]
  46. Nat Rev Mol Cell Biol. 2017 May;18(5):285-298 [PMID: 28225081]
  47. J Virol. 2020 Jan 31;94(4): [PMID: 31748390]
  48. Adv Exp Med Biol. 2019;1215:111-127 [PMID: 31317498]
  49. mBio. 2015 Jul 07;6(4):e00759 [PMID: 26152585]
  50. Science. 2020 Sep 11;369(6509):1395-1398 [PMID: 32763915]
  51. Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4931-4941 [PMID: 32075920]
  52. PLoS Biol. 2008 Sep 16;6(9):e226 [PMID: 18798692]
  53. Immunity. 2020 Jul 14;53(1):54-77 [PMID: 32668228]
  54. J Virol. 2014 Apr;88(8):4572-85 [PMID: 24478431]
  55. J Virol. 2013 Jan;87(1):372-83 [PMID: 23077311]
  56. J Biol Chem. 2019 May 3;294(18):7115-7127 [PMID: 30045872]
  57. PLoS Pathog. 2014 Mar 06;10(3):e1003971 [PMID: 24603687]
  58. Nature. 2018 Nov;563(7729):137-140 [PMID: 30333622]
  59. J Virol. 2006 Apr;80(8):3743-51 [PMID: 16571791]
  60. Future Virol. 2007 Mar;2(2):205-215 [PMID: 24093048]
  61. J Virol. 2012 Aug;86(15):8245-58 [PMID: 22623778]
  62. Nat Commun. 2018 Jan 4;9(1):54 [PMID: 29302061]
  63. J Biol Chem. 2019 Oct 4;294(40):14823-14835 [PMID: 31444270]
  64. Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):E5237-45 [PMID: 26351690]
  65. J Virol. 2019 Oct 15;93(21): [PMID: 31375591]
  66. Science. 2009 Nov 27;326(5957):1279-83 [PMID: 19965480]
  67. Nat Commun. 2018 May 23;9(1):2044 [PMID: 29795292]
  68. J Mol Biol. 2004 May 28;339(2):301-12 [PMID: 15136034]
  69. Nature. 2018 Jul;559(7713):211-216 [PMID: 29973724]
  70. Curr Top Microbiol Immunol. 2004;283:61-119 [PMID: 15298168]
  71. PLoS Pathog. 2016 Dec 9;12(12):e1006058 [PMID: 27936158]
  72. Sci Rep. 2017 Aug 9;7(1):7698 [PMID: 28794491]
  73. J Gen Virol. 2006 Jul;87(Pt 7):1805-1821 [PMID: 16760383]
  74. Nature. 2017 Nov 16;551(7680):394-397 [PMID: 29144446]
  75. Virology. 2001 Aug 15;287(1):171-82 [PMID: 11504552]
  76. Elife. 2016 Feb 15;5:e12627 [PMID: 26880565]
  77. Eur J Cell Biol. 2015 Jul-Sep;94(7-9):323-31 [PMID: 26070789]
  78. J Virol. 2003 Jul;77(14):7945-56 [PMID: 12829834]
  79. Viruses. 2014 Aug 07;6(8):3019-54 [PMID: 25105277]
  80. J Virol. 2016 Jul 27;90(16):7268-7284 [PMID: 27252530]
  81. Biochemistry. 2018 May 1;57(17):2499-2508 [PMID: 29509422]
  82. J Virol. 2009 Apr;83(7):3069-77 [PMID: 19153231]
  83. PLoS Pathog. 2012 Feb;8(2):e1002550 [PMID: 22383882]
  84. Cell Mol Life Sci. 2017 Sep;74(17):3091-3118 [PMID: 28600653]
  85. J Infect Dis. 2007 Nov 15;196 Suppl 2:S284-90 [PMID: 17940962]
  86. Science. 2009 Jun 26;324(5935):1729-32 [PMID: 19460965]
  87. J Cell Sci. 2021 Mar 4;134(5): [PMID: 33664154]
  88. PLoS Pathog. 2016 Oct 17;12(10):e1005942 [PMID: 27749929]
  89. J Biol Chem. 2016 Mar 25;291(13):6696-705 [PMID: 26851279]
  90. Nucleic Acids Res. 2012 Mar;40(5):2197-209 [PMID: 22075989]
  91. Mol Cell. 2002 Aug;10(2):307-16 [PMID: 12191476]
  92. Virus Res. 2019 Apr 2;263:217-225 [PMID: 30772332]
  93. Trends Microbiol. 2020 Dec;28(12):1022-1033 [PMID: 32536523]
  94. Annu Rev Phys Chem. 2020 Apr 20;71:53-75 [PMID: 32312191]
  95. Microbes Infect. 2002 Apr;4(4):491-500 [PMID: 11932200]
  96. Cell Host Microbe. 2009 Apr 23;5(4):365-75 [PMID: 19380115]
  97. Curr Opin Virol. 2011 Nov;1(5):381-7 [PMID: 22440839]
  98. J Virol. 2008 Mar;82(6):2699-704 [PMID: 18199658]
  99. Mol Cell. 2018 Jan 4;69(1):136-145.e6 [PMID: 29290611]
  100. Nat Commun. 2017 Nov 9;8(1):1396 [PMID: 29123131]
  101. J Virol. 2015 Dec 30;90(6):2849-57 [PMID: 26719278]
  102. Sci Rep. 2013;3:1206 [PMID: 23383374]
  103. Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14402-7 [PMID: 23940347]
  104. PLoS Pathog. 2019 Aug 5;15(8):e1007995 [PMID: 31381607]
  105. Viruses. 2021 Jan 18;13(1): [PMID: 33477448]
  106. Virology. 2007 Dec 20;369(2):309-23 [PMID: 17825340]
  107. Nucleic Acids Res. 2019 Jun 20;47(11):5837-5851 [PMID: 31066445]
  108. J Immunol. 2019 Feb 1;202(3):841-856 [PMID: 30598516]
  109. Curr Biol. 2017 Oct 23;27(20):R1097-R1102 [PMID: 29065286]
  110. J Virol. 2005 Jun;79(12):7673-81 [PMID: 15919920]
  111. Trends Biochem Sci. 2018 Jul;43(7):499-516 [PMID: 29716768]
  112. Cell Rep. 2017 Jul 25;20(4):895-908 [PMID: 28746874]
  113. Mol Cell. 2015 Oct 15;60(2):208-19 [PMID: 26412307]
  114. Curr Opin Struct Biol. 2017 Jun;44:18-30 [PMID: 27838525]
  115. J Virol. 2015 Mar;89(6):3188-99 [PMID: 25552722]
  116. Cell. 2019 Jan 24;176(3):419-434 [PMID: 30682370]
  117. Vaccine. 2012 Dec 7;30(51):7359-67 [PMID: 23063835]
  118. Curr Genet. 2019 Jun;65(3):691-694 [PMID: 30603876]
  119. J Infect Dis. 2015 Oct 1;212 Suppl 2:S160-6 [PMID: 26038396]
  120. J Virol. 2011 Feb;85(3):1391-5 [PMID: 21106738]
  121. Sci Adv. 2018 Aug 22;4(8):eaat7778 [PMID: 30140745]
  122. Microbes Infect. 2018 Jun - Jul;20(6):360-368 [PMID: 29886262]
  123. J Virol. 2012 May;86(9):4743-51 [PMID: 22345440]
  124. Virus Res. 1995 Dec;39(2-3):129-50 [PMID: 8837880]
  125. Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27676-27684 [PMID: 33077592]
  126. J Virol. 2015 Apr;89(8):4227-36 [PMID: 25631085]
  127. Cell. 2020 Apr 16;181(2):306-324.e28 [PMID: 32302570]
  128. Trends Cell Biol. 2006 Jan;16(1):19-26 [PMID: 16325406]
  129. J Gen Virol. 2006 Mar;87(Pt 3):665-672 [PMID: 16476989]
  130. Virology. 2015 May;479-480:545-54 [PMID: 25683441]
  131. EMBO J. 2016 Aug 1;35(15):1603-12 [PMID: 27357569]
  132. Annu Rev Cell Dev Biol. 2014;30:39-58 [PMID: 25288112]
  133. J Virol. 2014 Mar;88(6):3067-76 [PMID: 24335286]
  134. Cell. 2018 Jul 26;174(3):688-699.e16 [PMID: 29961577]
  135. J Infect Dis. 2011 Nov;204 Suppl 3:S892-6 [PMID: 21987766]
  136. Arch Virol. 2019 Jul;164(7):1967-1980 [PMID: 31089958]
  137. J Virol. 2016 Jan 20;90(7):3676-83 [PMID: 26792749]
  138. J Virol. 2013 Feb;87(3):1333-47 [PMID: 23152511]
  139. RNA. 2019 Mar;25(3):279-285 [PMID: 30587495]
  140. PLoS Pathog. 2019 Apr 29;15(4):e1007733 [PMID: 31034506]
  141. J Virol. 2020 Apr 16;94(9): [PMID: 32102881]
  142. J Virol. 2015 Feb;89(3):1640-51 [PMID: 25410852]
  143. Respiration. 1995;62(1):27-33 [PMID: 7716351]
  144. Cell Rep. 2019 Sep 17;28(12):3032-3046.e6 [PMID: 31533029]
  145. J Virol. 2002 Sep;76(17):8532-9 [PMID: 12163572]
  146. Science. 2020 Jan 31;367(6477): [PMID: 32001628]
  147. Trends Cell Biol. 2018 Jun;28(6):420-435 [PMID: 29602697]
  148. Sci Rep. 2021 Feb 4;11(1):2985 [PMID: 33542394]
  149. J Virol. 2018 Feb 12;92(5): [PMID: 29237839]
  150. PLoS Pathog. 2006 Sep;2(9):e99 [PMID: 17009868]
  151. Cell Microbiol. 2008 Oct;10(10):2012-28 [PMID: 18547336]
  152. Virology. 2021 May;557:86-99 [PMID: 33677389]
  153. Virology. 1998 Sep 30;249(2):406-17 [PMID: 9791031]
  154. Viruses. 2021 Feb 25;13(3): [PMID: 33669141]
  155. Viruses. 2019 Jan 03;11(1): [PMID: 30609802]
  156. Cell Commun Signal. 2016 Jan 05;14:1 [PMID: 26727894]
  157. Science. 2018 Jan 5;359(6371): [PMID: 29301985]
  158. Viruses. 2021 May 05;13(5): [PMID: 34063087]
  159. J Virol. 2010 Aug;84(15):7543-57 [PMID: 20484502]
  160. Biochim Biophys Acta Mol Cell Res. 2020 Dec;1867(12):118831 [PMID: 32835749]
  161. Virology. 1961 Aug;14:410-6 [PMID: 13775539]
  162. Sci Adv. 2020 Apr 01;6(14):eaaz7095 [PMID: 32270045]
  163. RNA Biol. 2021 Apr;18(4):523-536 [PMID: 32882148]
  164. Virus Res. 2003 Mar;92(1):89-98 [PMID: 12606080]
  165. J Mol Recognit. 2010 Sep-Oct;23(5):435-47 [PMID: 20058326]
  166. J Biol Chem. 2020 Nov 9;: [PMID: 33168632]
  167. J Virol. 2014 Jan;88(1):456-68 [PMID: 24155404]
  168. mBio. 2017 Nov 21;8(6): [PMID: 29162711]
  169. Methods Enzymol. 2018;611:1-30 [PMID: 30471685]
  170. J Virol. 2014 Sep;88(18):10511-24 [PMID: 24965473]
  171. ACS Cent Sci. 2019 May 22;5(5):821-830 [PMID: 31139718]
  172. Virology. 1997 Jun 9;232(2):260-8 [PMID: 9191839]
  173. Curr Opin Virol. 2020 Apr;41:52-58 [PMID: 32413678]
  174. Mol Cell Proteomics. 2010 Sep;9(9):1829-48 [PMID: 20530633]
  175. Nat Commun. 2017 Jul 5;8(1):58 [PMID: 28680096]
  176. Science. 2006 Jul 21;313(5785):357-60 [PMID: 16778022]
  177. Science. 2006 Jul 21;313(5785):360-3 [PMID: 16778023]
  178. J Virol. 2016 Apr 29;90(10):4914-4925 [PMID: 26937028]
  179. Wiley Interdiscip Rev RNA. 2019 Mar;10(2):e1514 [PMID: 30362243]
  180. Mol Cell. 2020 Sep 17;79(6):978-990.e5 [PMID: 32857953]
  181. Curr Opin Chem Eng. 2019 Mar;23:92-98 [PMID: 32802734]
  182. J Virol. 2017 Nov 30;91(24): [PMID: 28978704]
  183. J Biol Chem. 2003 May 16;278(20):18638-48 [PMID: 12621042]
  184. J Cell Biol. 2006 Mar 13;172(6):803-8 [PMID: 16520386]
  185. PLoS Pathog. 2018 Feb 28;14(3):e1006920 [PMID: 29489893]
  186. J Virol. 1996 Feb;70(2):801-8 [PMID: 8551618]
  187. J Virol. 2017 Jul 27;91(16): [PMID: 28566377]
  188. Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4334-9 [PMID: 21368180]
  189. Int J Mol Sci. 2019 Nov 05;20(21): [PMID: 31694155]
  190. Viruses. 2020 Mar 20;12(3): [PMID: 32245118]
  191. Viruses. 2020 Jul 30;12(8): [PMID: 32751700]
  192. PLoS Pathog. 2010 Jun 24;6(6):e1000958 [PMID: 20585632]
  193. Mol Cell. 2013 Jun 6;50(5):613-23 [PMID: 23746349]
  194. Annu Rev Plant Biol. 2021 Jun 17;72:17-46 [PMID: 33684296]
  195. PLoS Pathog. 2013;9(5):e1003358 [PMID: 23671419]
  196. Science. 2012 Aug 31;337(6098):1047-9 [PMID: 22936764]
  197. Front Microbiol. 2019 Jul 10;10:1490 [PMID: 31354644]
  198. J Infect Dis. 2007 Nov 15;196 Suppl 2:S247-50 [PMID: 17940956]
  199. J Infect Dis. 2011 Nov;204 Suppl 3:S878-83 [PMID: 21987764]
  200. Virus Res. 2017 Apr 15;234:87-102 [PMID: 28104450]
  201. J Virol. 2014 Sep;88(18):10851-63 [PMID: 25008930]
  202. mBio. 2018 Sep 4;9(5): [PMID: 30181255]
  203. J Biol Chem. 2019 May 3;294(18):7137-7150 [PMID: 30587571]
  204. J Virol. 2006 Mar;80(5):2318-25 [PMID: 16474138]
  205. J Virol. 1999 Jan;73(1):297-306 [PMID: 9847333]
  206. Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9839-44 [PMID: 21613569]
  207. J Virol. 2012 Nov;86(21):11779-88 [PMID: 22915810]
  208. Cell. 2016 Jun 16;165(7):1686-1697 [PMID: 27212236]
  209. PLoS Biol. 2020 Jun 8;18(6):e3000715 [PMID: 32511245]
  210. J Virol. 2012 Oct;86(20):11301-10 [PMID: 22875974]
  211. PLoS One. 2012;7(8):e43031 [PMID: 22912779]
  212. J Virol. 2020 Jul 30;94(16): [PMID: 32493824]
  213. PLoS Pathog. 2012;8(12):e1003056 [PMID: 23236278]
  214. J Virol. 2009 Aug;83(16):7948-58 [PMID: 19494013]
  215. Microbiol Mol Biol Rev. 2011 Sep;75(3):468-90, second page of table of contents [PMID: 21885681]
  216. Cells. 2020 May 01;9(5): [PMID: 32370067]
  217. J Cell Biol. 2021 Mar 1;220(3): [PMID: 33502444]
  218. J Virol. 2017 Jan 18;91(3): [PMID: 27881643]

MeSH Term

Animals
Humans
Inclusion Bodies, Viral
Negative-Sense RNA Viruses
RNA Virus Infections

Word Cloud

Created with Highcharts 10.0.0viralcondensatesRNAinclusionbodiescellularbiomolecularNIBsreplicationLLPSPInfectionsnegativestrandvirusesNSVsformationcellmembrane-lesscompartmentsarchitecturepropertiesliquid-liquidphaseseparationmoleculesViralexpressionnucleoproteinphosphoproteinproteininducehostsegregatewellproteinsenableefficientinductionleadsinevitablystructuralremodelingRecentstudiessuggestedliquidorganellespreviouslyshownlikestressgranulesP-bodiesBiomolecularhighlydynamicstructuresformedKeydriverscellsmultivalentprotein:proteinprotein:RNAinteractionsleadingspecializedareasrecruitsimilarnon-similarexcludedtypicalfeaturesalsocommoncharacteristicbiogenesispredominantlyinducedNPcharacterizedspecialcontainingmultipledisorderedregionsRNA-bindingdomainscontributedifferentfunctionskeepssolubleallowconcertedbindingresultsencapsidationgenomeactsadditionallycofactorpolymeraseenablingtranscriptionwillreviewfunctionuponinfectionrespectnatureNewPerspectivesBiogenesisInclusionBodiesNegative-SenseVirusNSV

Similar Articles

Cited By